79 filings
Page 2 of 4
CORRESP
0ofs 3o5wbt
12 May 23
Correspondence with SEC
12:00am
8-K
y9kbfggqudnyu5j61cns
9 May 23
Results of Operations and Financial Condition
6:45am
DEFA14A
21n176 5hu
3 May 23
Additional proxy soliciting materials
4:15pm
DEFA14A
gdvdp 23q8q3
1 May 23
Additional proxy soliciting materials
12:55pm
ARS
fc8u0
1 May 23
Annual report to shareholders
12:45pm
CORRESP
3oiok0u
17 Apr 23
Correspondence with SEC
12:00am
UPLOAD
hze7e
14 Apr 23
Letter from SEC
12:00am
S-8
jfbdei48iin
10 Mar 23
Registration of securities for employees
3:07pm
8-K
xi8tx18k691epvc1
7 Mar 23
Results of Operations and Financial Condition
7:36am
8-K
8e895iusprm17htca
24 Feb 23
Departure of Directors or Certain Officers
4:10pm
8-K
mc479
11 Jan 23
Enfusion Names Michael Spellacy as Board Chair and Non-Executive Director
4:15pm
8-K
bzl8bjxe1ce2a9v8pp31
22 Dec 22
Enfusion Names Oleg Movchan as Chief Executive Officer
5:09pm
8-K
0rwons7j
19 Dec 22
Enfusion Appoints Brad Herring as New Chief Financial Officer
4:37pm
EFFECT
7bxefsx5
5 Dec 22
Notice of effectiveness
12:15am
8-K
xlavf64e wdr
30 Nov 22
Enfusion Welcomes New Addition to Board of Directors
4:15pm
UPLOAD
g4om8sej3 70td
30 Nov 22
Letter from SEC
12:00am
CORRESP
qpw1cj0os6p8gl81jpgr
30 Nov 22
Correspondence with SEC
12:00am